FDA recall record

Bio-pharm Ranitidine Syrup recall — FDA D-0809-2016

Failed Impurities/Degradation Specifications: Product recalled due to elevated impurity result detected during routine stability testing.

Class IIIclassification
D-0809-2016official record ID
Apr 13, 2016report date

Recall record at a glance

Official recordD-0809-2016
CategoryDrug Recalls
ClassificationClass III
FDA record statusTerminated
Recalling firmBio-pharm, Inc.
Report dateApr 13, 2016
Recall initiation dateDec 17, 2015
Quantity103,664 Bottles
LocationLevittown, PA, United States

Official product description

Ranitidine Syrup (Ranitidine Oral Solution, USP), 15 mg/mL (75 mg/5 mL), 16 fl oz Bottle, Rx only, Mfd For: Heritage Pharmaceuticals Inc., Eatontown, NJ 07724, NDC 23155-291-51

Why the product was recalled

Failed Impurities/Degradation Specifications: Product recalled due to elevated impurity result detected during routine stability testing.

Distribution information

Nationwide and Puerto Rico

How to read the classification

FDA Class III generally covers situations in which use of or exposure to the product is not likely to cause adverse health consequences. The classification displayed here is taken from the FDA enforcement record.

Additional record details

Recall type: Voluntary: Firm initiated. Initial notification: Letter.

What to do next

If you believe you have the recalled product, use the recall number and firm information above to confirm the official notice and follow the instructions issued by the FDA, recalling firm, retailer or product manufacturer. For drugs and medical devices, decisions about treatment or medical care should be discussed with a qualified health professional.

About this record

Recall Lookup USA preserves the most complete source information successfully retrieved. We do not create missing facts or infer affected lots or VINs. The official record may still change, so use the identifier above when verifying current instructions.

FDA source limitation: openFDA enforcement reports are a reference dataset, not a live public-alert or recall-lifecycle service. FDA notes that enforcement-report status may not be updated after classification. Confirm current actions with the FDA, recalling firm or appropriate healthcare professional when relevant.

Related recall records

Other records from the same recalling company are shown first when available.